Director Ilan Ganot of Solid Biosciences Inc. filed a Form 4 on October 26, 2026, reporting the acquisition of 150,000 restricted stock units granted on October 1, 2026, held indirectly through his wife.

Key Highlights

  • Grant date: Ilan Ganot received 150,000 restricted stock units on October 1, 2026.
  • Vesting schedule: The RSUs vest in full on October 1, 2029, subject to continued service through that date, according to the filing.
  • Price: The derivative security was acquired at a price of $0.00, as reported.
  • Indirect ownership: The 150,000 RSUs are held indirectly, with the nature of indirect beneficial ownership listed as "Wife."
  • Underlying security: Each RSU represents a contingent right to receive one share of Solid Biosciences Inc. common stock.
  • Post-transaction holdings: Following the reported transaction, Ganot beneficially owns 150,000 derivative securities, per the filing.

Solid Biosciences Director Ganot RSU Grant Details

According to the Form 4 filed with the U.S. Securities and Exchange Commission on October 26, 2026, Ilan Ganot, a director of Solid Biosciences Inc. (NASDAQ:SLDB), reported the acquisition of 150,000 restricted stock units on October 1, 2026. The filing states that each RSU "represents a contingent right to receive one share of the issuer's common stock."

The filing discloses that the RSUs "were granted on October 1, 2026 and vest in full on October 1, 2029, subject to Ms. Ganot's continued service through the vesting date." The transaction code reported is "A" (acquired), and the price of the derivative security is listed as $0.00. The 150,000 RSUs are recorded as indirectly owned, with the nature of that indirect ownership identified in the filing as "Wife."

The Form 4 was signed by Kimberly Cornwell as attorney-in-fact for Ilan Ganot and dated October 26, 2026. No non-derivative securities transactions were reported in Table I of the filing.

What Was Disclosed

Director Ilan Ganot of Solid Biosciences Inc. disclosed the acquisition of 150,000 RSUs on October 1, 2026, held indirectly through his wife, with full vesting scheduled for October 1, 2029, contingent on continued service.